Kodiak Sciences (KOD) Common Equity (2017 - 2026)

Kodiak Sciences' Common Equity history runs 10 years deep, the most recent figure standing at $112.1 million for Q1 2026.

• Quarterly Common Equity rose 2.99% year-over-year to $112.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $112.1 million (up 2.99% YoY) and the FY2025 annual result came in at $157.4 million, up 4.72% from the prior year.
• Common Equity was $112.1 million for Q1 2026 at Kodiak Sciences, down from $157.4 million in the prior quarter.
• Across five years, Common Equity topped out at $597.4 million in Q1 2022 and bottomed at $23.7 million in Q3 2025.
• A 5-year average of $271.0 million and a median of $241.2 million in 2024 frame the typical range for Common Equity.
• Peak annual rise in Common Equity reached 4.72% in 2025, while the deepest fall reached 87.22% in 2025.
• Kodiak Sciences' Common Equity stood at $436.2 million in 2022, then sank by 39.06% to $265.8 million in 2023, then tumbled by 43.45% to $150.3 million in 2024, then gained by 4.72% to $157.4 million in 2025, then fell by 28.77% to $112.1 million in 2026.
• Business Quant data shows KOD's Common Equity at $112.1 million in Q1 2026, $157.4 million in Q4 2025, and $23.7 million in Q3 2025.